research Evaluation of Vitamin D Levels in Chronic Telogen Effluvium Patients
Vitamin D levels are not correlated with chronic hair loss in Telogen Effluvium patients.
Search
for
Sort by
Research
180-210 / 1000+ results 
research Distinct Expression Profile of Stem Cell Markers, LGR5 and LGR6, in Basaloid Skin Tumors
LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.
research Sodium Metabisulfite: Effects on Ionic Currents and Excitotoxicity
Sodium metabisulfite increases sodium channel activity, leading to higher cell excitability and potential damage.
research Acute Telogen Effluvium: A Post-Covid-19 Sequela
COVID-19 infection may cause hair loss.
research Dermatological Aspects of Synthetic Cannabinoid Addiction
Synthetic cannabinoid addiction can cause skin problems like acne and hair loss.
research Comparative Evaluation Between Two Nutritional Supplements in the Improvement of Telogen Effluvium
One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.
research Finasteride Alleviates High Fat Associated Protein-Overload Nephropathy by Inhibiting Trimethylamine N-Oxide Synthesis and Regulating Gut Microbiota
Finasteride may help treat kidney disease caused by a high-fat diet by reducing harmful toxins and improving gut bacteria.
research Role of Oxidative Stress in Polycystic Ovary Syndrome
Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.
research Serum Ferritin and Vitamin D in Female Hair Loss: Do They Play a Role?
Low iron and vitamin D levels are linked to hair loss in women.
research The Role of Anemia and Vitamin D Levels in Acute and Chronic Telogen Effluvium
Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.
research Covid Induced Telogen Effluvium: An Insight
COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.
research Characterization of Response of Murine Hair Follicle-Derived Keratinocytes Against Androgen and Testosterone 5α-Reductase Activity
Mouse hair cells respond to male hormones by growing less, and this can be stopped by certain blockers.
research Ranitidine And Finasteride Inhibit The Synthesis And Release Of Trimethylamine N-Oxide And Mitigate Its Cardiovascular And Renal Damage Through Modulating Gut Microbiota
Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.
research Evaluation of the Relationship Between Favipiravir Use and Telogen Effluvium in COVID-19 Patients
Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.
research A Case of Telogen Effluvium as COVID Sequelae
A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.
research Culprits of Medication-Induced Telogen Effluvium, Part 1
Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.
research Study of the Thyroid Profile of Patients with Alopecia
People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.
research Optimal Starting Dose of Clomiphene Citrate for Ovulation Induction in Anovulatory PCOS Women
Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.
research The Development and Validation of the Hair Shedding Visual Scale for Asian Women (HSVS-A)
The HSVS-A is an effective tool for quickly screening hair shedding in Asian women.
research Association Between Hair Diseases and COVID-19 Pandemic-Related Stress: A Cross-Sectional Study Analysis
The study suggests pandemic stress might worsen or trigger hair loss problems.
research Prevalence of Telogen Effluvium Hair Loss in COVID-19 Patients and Its Relationship with Disease Severity
COVID-19 patients may experience hair loss, but it's not linked to their age or sex.
research Evaluating the Difference Between COVID-19-Associated Telogen Effluvium and Telogen Effluvium Due to Other Causes
COVID-19-related hair loss may have unique features compared to hair loss from other causes.
research Assessment of Heavy Metal and Trace Element Levels in Patients with Telogen Effluvium
Heavy metals might contribute to hair loss in Telogen Effluvium.
research Etiological Role of Ferritin and Vitamin D in Patients with Telogen Effluvium
Low ferritin levels might be linked to telogen effluvium, but vitamin D levels are not.
research The Role of Ferritin and Vitamin D Levels in Telogen Effluvium
Low vitamin D levels, not ferritin levels, were found in patients with hair loss condition telogen effluvium.
research Evaluation of Thyroid Autoimmunity in Female Patients with Telogen Effluvium
Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.
research A Study of the Clinical Patterns of Hair Loss in Female Patients
Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.
research ULBP3: A Marker for Alopecia Areata Incognita
ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.
research Androgenetic Alopecia: A Review and Emerging Treatments
Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.
research Post-Finasteride Syndrome: A Review of Current Literature
Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.